(Date:11/6/2009)...ewswire/ -- Plan International, a leading children...ntries around the world, has been asked to deliver...-being at the upcoming American Public Health Asso...n Philadelphia, Pennsylvania on November 7-11, 200...athers organizations together to address current a...
(Date:11/6/2009)...programs, expert says , , FRIDAY, Nov. 6...e difficult than ever before for many Americans to...ons are available, according to an expert from But...o your pharmacist, advised Carriann Richey, direct... practice at Butler,s College of Pharmacy and Heal...
(Date:11/6/2009)...Value-Added Distributor to Offer VistaMAX®, BW... (PRWEB) November 6, 2009 -- W... security, RFID, VoIP and portable data-collection...ecima Networks Inc. (TSX:VCM), a leading provider ... wireless and telephony networks. The partnership ...
(Date:11/6/2009)...ent and CEO of the National Council on Aging: ,...e National Council on Aging urges the House to pas... 3962), which we regard as a historic step toward ...are for Americans of all ages. ,, After a caref...a good deal for America,s seniors. H.R. 3962 would...
(Date:11/6/2009)...on Benefit Group, the health and welfare benefits ...nounced employer health cost reduction initiatives...ith U.S.-based healthcare company Concentra. ,,...0415/CG99351LOGO ) ,, Lockton has named Concent...ents with: ,, Health promotion Wellness progr...
Breaking Medicine News(10 mins):Health News:Plan's Expertise Highlighted at Premier Health Forum 2Health News: Pay Less for Prescription Drugs 2Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3Health News:NCOA Supports H.R. 3962, the Affordable Health Care for America Act 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 3...male staff member at a Sydney maternity hospital w...lt, around 50 families may have to be given antibi... was working at the women and babies facility of R...ber ceased all contact with patients and families ...
...arch from Mayo Clinic estimates that about 5 milli...alve disease as a consequence of aging, according ...ancet.
While rheumatic fever was previously ...in this country today, thanks to antibiotic therap...
...th Minister P.K. Sreemathy inagurated a project th...which are "textiles that have been dyed in medicin...t the Government Ayurveda College in Thiruvanantha...vyaguna Vijnan, Government Ayurveda College. The p...
...ntists in the US have claimed today that they have...s without destroying embryos.//
The scientis... that this development could create the way for th.... Robert Lanza, the vice president of U.S. biotech...
...alth warning has been issued in Gujarat's flood-ra...cted Hantavirus pulmonary syndrome - a disease tha....
The deadly virus affects the kidneys, lungs...ince the possibility of contracting the virus is h...
...ya Pradesh is forming a network of youth, called t...DS.//
The networking process, started recent...e deadly disease that has affected 1,806 people so...on Clubs to safeguard People Living With HIV and A...
Other Medicine News:Health News:Valve Disease Study Suggests New Public Health Concern 2Health News:Valve Disease Study Suggests New Public Health Concern 3(Date:11/6/2009)...FirstCall/ -- Virtual Health Technologies, Inc. (O...previously confirmed Letter of Intent to sell all ...hnologies, Inc (WNDM) is subject to final approval...GI. ,, Shareholder Assurances ,, "We bel...ream and cash realized from the transaction would ...
(Date:11/6/2009)...Call/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ),...t of small-molecule therapeutics for the treatment...(HIV), today reported recent accomplishments and f...nths ended September 30, 2009. ,, (Logo: htt...O ) ,, "Since our last quarterly update, we hav...
(Date:11/6/2009)...ll/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ann...lts for the second quarter ended October 23, 2009 ...day, November 18, 2009 at 5:00 PM EST. The compan...results on Thursday, November 19, 2009 at 9:00 AM ...ts Conference Call Instructions ,, To listen ...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 1Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 2Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 3MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 1MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 2MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 3MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 4MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 5InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 14290 1InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 14290 2...-- Expression,Genetics, Inc., announced today the ...the Company,s lead drug candidate,EGEN-001. The s...rmingham and , evaluated the safety, tolerance, pr... EGEN-001 in 13 patients,with advanced recurrent e...he Company,s proprietary TheraPlas(R) delivery,tec...
...os Cancer,Institute physician-scientists today rep... disparities in patients with,gynecologic cancer a...al meeting in Los Angeles, CA. , Caucasian patient...live longer than their African American counterpar...sor of gynecologic,oncology, Karmanos Cancer Insti...
Other Medicine Technology:Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 2Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 3Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 4Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3SureSigns VS1 Vital Signs Monitor
... continuous monitoring, the M3 and M4 monitors off...onatal patient care. M Series monitors are equippe...basic set of non-invasive parameters and input for...Measurement Server extensions offer Mainstream or ...
...lp (OLEH), an interactive electronic textbook, pro...ted information. OLEH brings clinical decision sup...ost right on the patient monitor screen while tak... reduction and greater efficiencies with practical...
MP30
Medicine Products: